Proof of Usefulness Report

DRG Abacus

Analysis completed on 1/25/2026

+21

Proof of Usefulness Score

You're In Business

The submission references 'DRG Abacus', a legitimate legacy health economics consultancy, but the entry contains severe red flags indicating low data integrity or spam. Claims such as 'most people have used my product' and an audience of 'everyone' are objectively false for a niche B2B pharma consultancy. Additionally, a stated market cap of 50,000 for a 125-person company is nonsensical. While the underlying entity (if authentic) has value, the submission quality is too poor and contradictory to warrant a passing score.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+70

Audience Reach Impact+30

Technical Innovation+30

Evidence Of Traction+20

Market Timing Relevance+50

Functional Completeness+10

Subtotal+19.25

Usefulness Multiplierx1.1

Final Score+21

Project Details

Project URL

drgabacus.com

Description

DRG Abacus, a Decision Resources Group company formally known as Abacus International, specialises in health outcomes, economic modelling, HTA, medical writing and market access services. Our client base includes the global and local affiliates of many of the leading pharmaceutical and medical device companies. DRG Abacus' key deliverables include: Payer landscaping Clinical outcomes assessment Systematic review Health economics Health technology assessment Value communications MedTech Access@teamdrg.com

Algorithm Insights

Market Position

Growing utility with room for optimization

User Engagement

Documented reach suggests active user community

Technical Stack

Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline